A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE. (Q47685491)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE. (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

darbepoetin alfa

0 references

quality of life

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

author name string

Simon D Roger

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

Sarbjit V Jassal

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

Michael C Woodward

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

Steven Soroka

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

Lawrence P McMahon

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

publication date

28 August 2013

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

International Urology and Nephrology

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

46

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

469-475

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

Progression of kidney dysfunction in the community-dwelling elderly

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Detecting chronic kidney disease in older people; what are the implications?

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Anemia is associated with disability and decreased physical performance and muscle strength in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the "Health and Anemia" study

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Diminished quality of life and physical function in community-dwelling elderly with anemia

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Using the SF-36 with older adults: a cross-sectional community-based survey

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Health-related quality of life and hemoglobin levels in chronic kidney disease patients

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Quality of life in CKD patients treated with erythropoiesis-stimulating agents.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0512-1

21 January 2018

Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaemia in older persons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KHA-CARI guideline: biochemical and haematological targets: haemoglobin concentrations in patients using erythropoietin-stimulating agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Physical Performance after Treatment of Renal Anemia with Recombinant Human Erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23982766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11255-013-0512-1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/23982766

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47685491&oldid=1516726993"